LEADER 02328oas  2200949 a 450 
001 9910446357403321
005 20260126220630.0
011   $a1473-6535
035   $a(DE-599)ZDB2026990-0
035   $a(DE-599)2026990-0
035   $a(OCoLC)36903805
035   $a(CONSER)  2001214004
035   $a(CKB)954925577051
035   $a(EXLCZ)99954925577051
100   $a19970514a19909999  sy         a
101 0 $aeng
135   $aurmnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCurrent opinion in lipidology
210   $a[Oxford] $cRapid Science Publishers
210 3 $aLondon, UK $cLippincott Williams & Wilkins
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311 08$a0957-9672 
531 0 $aCurr. opin. lipidol.
606   $aLipids$vPeriodicals
606   $aLipids$vBibliography$vPeriodicals
606   $aLipids
606   $aReview Literature as Topic
606   $aLipides$vPe?riodiques
606   $aLipides$vBibliographie$vPe?riodiques
606   $aLipids$2fast$3(OCoLC)fst00999367
606   $aLipoprotei?nen$2gtt
606   $aAtherosclerosis obliterans$2gtt
608   $aIndex.
608   $aPeriodical.
608   $aBibliographies.$2fast
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
615  0$aLipids
615  0$aLipids
615  2$aLipids.
615  2$aReview Literature as Topic.
615  6$aLipides
615  6$aLipides
615  7$aLipids.
615 17$aLipoprotei?nen.
615 17$aAtherosclerosis obliterans.
676   $a616
801  0$bF#A
801  1$bF#A
801  2$bOCL
801  2$bNSD
801  2$bOCLCQ
801  2$bSBH
801  2$bOCLCQ
801  2$bBUF
801  2$bDLC
801  2$bOCLCQ
801  2$bOCLCF
801  2$bOCLCQ
801  2$bAU@
801  2$bOCLCO
801  2$bUKMGB
801  2$bOCLCA
801  2$bTKN
801  2$bVT2
801  2$bOCLCO
801  2$bOCLCA
801  2$bOCL
801  2$bOCLCQ
801  2$bUBY
801  2$bU3W
801  2$bOCLCL
801  2$bAAE
801  2$bOCLCQ
906   $aJOURNAL
912   $a9910446357403321
996   $aCurrent opinion in lipidology$9797532
997   $aUNINA